Law360, New York (February 09, 2012, 5:22 PM ET) -- A New York federal judge on Thursday ruled that a group of Chinese companies cannot appeal his denial of their bid to exit multidistrict antitrust litigation over vitamin C, despite their claim that the Chinese government compelled them to fix prices.
U.S. District Judge Brian M. Cogan in September rejected HeBei Welcome Pharmaceutical Co. Ltd., Aland (Jiangsu) Nutraceutical Co. Ltd., Northeast Pharmaceutical Group Co. Ltd. and Shijiazhuang Pharma Weisheng Pharmaceutical (Shijiazhuang) Co. Ltd.'s contention that they were entitled to summary judgment because the Chinese government had...
No Quick Appeal For Chinese Cos. In Vitamin C MDL
To view the full article, take a free trial now.
